查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1856524

局部麻醉剂市场按给药途径、药物类别、产品类型、剂型、最终用户、分销管道和应用划分－全球预测，2025-2032年

Local Anesthesia Drugs Market by Route Administration, Drug Class, Product Type, Formulation, End-User, Distribution Channel, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，局部麻醉剂市场规模将成长至 43.4 亿美元，复合年增长率为 5.64%。

关键市场统计数据
基准年 2024 28亿美元
预计年份：2025年 29.6亿美元
预测年份 2032 43.4亿美元
复合年增长率 (%) 5.64%

全面介绍了正在改变全球局部麻醉护理格局的临床需求、製剂进步和商业性因素。

局部麻醉剂支持无数日常临床操作，从常规牙科手术到门诊和住院环境中复杂的局部麻醉手术。过去十年，药物动力学、製剂和给药系统的改进重新定义了人们对局部麻醉剂在手术全期流程中的战略重要性。临床医生要求局部麻醉剂具有可预测的阻滞效果，且全身影响最小；管理者寻求在各种医疗环境中都能发挥其价值；而生产商则必须在创新、监管严格性和生产扩充性之间取得平衡。

分析重塑局部麻醉治疗竞争格局的关键技术、临床、供应链和数位健康变化。

近期趋势已超越简单的产品替代，涵盖了局部麻醉的研发、生产、应用和报销方式的根本性变化。製剂技术的进步正在研发出作用时间更长、靶向性更强的药物，而联合用药方案和基于器械的给药系统则使临床医生能够根据每项手术的具体需求定制麻醉方案。同时，人们越来越关注减少阿片类药物的使用和优化术后恢復途径，这促进了跨学科合作，并提升了局部麻醉剂在多模态镇痛策略中的作用。

深入分析2025年美国关税如何改变了局部麻醉剂供应链的筹资策略、生产布局和采购决策

2025年美国关税政策对局部麻醉产品的生产、采购、定价策略和长期供应链规划产生了连锁反应。原料药和关键辅料进口关税的提高增加了到岸成本，并挤压了依赖全球供应商的製造商的利润空间。为此，采购团队加快了寻找替代供应商的步伐，并扩大了双重筹资策略，以降低单一国家供应中断的风险。

整合给药途径、药物类别、产品类型、剂型、终端用户行为、分销管道和临床应用等因素，提供高级细分洞察，从而指导您的策略。

细分市场层面的动态变化揭示了产品开发和商业化策略中存在的细微机会和限制。从给药途径来看，临床实践区分了用于浅表手术的浸润麻醉技术和需要精准、长效药物的神经阻断麻醉；局部和脊髓给药要求产品具有可预测的扩散范围和最小的全身毒性；而局部用药製剂则强调快速起效和最小刺激性，适用于皮肤科和轻微牙科应用。每种给药途径都有其自身的临床医生培训需求、器械相容性考虑因素和安全性特征，这些因素都应影响製剂和包装的选择。

战略区域视角，重点关注美洲、欧洲、中东和非洲以及亚太市场在监管预期、采购惯例和临床应用方面的差异

区域差异持续对产品优先顺序和市场推广策略产生重要影响。在美洲，先进的临床基础设施、庞大的门诊病人以及不断提高的支付方期望共同推动了长效製剂、预填充系统以及支持减少阿片类药物使用方案的解决方案的发展。该地区的供应链策略体现了国内生产与依赖成熟国际供应商之间的平衡，采购团队倾向于选择那些能够证明符合监管要求和物流可靠性的合作伙伴。

透过揭示创新者、非专利生产商、合约生产商和设备整合商之间的竞争格局，塑造局部麻醉剂开发和商业化的未来。

公司层面的动态反映了创新药厂、非专利生产商、合约生产商和器材-药物整合商之间的竞争关係。创新药企持续投资于缓释性化学技术和专有给药平台，以在持续时间、安全性和给药便利性方面实现差异化。这些投资通常辅以针对性的临床项目，以证明其在特定手术终点和患者报告结果方面的益处。同时，学名药生产商在商品化领域仍保持着重要的影响力，在这些领域，成本效益和供应可靠性是关键的采购驱动因素，尤其是在牙科和基础浸润麻醉等大批量应用领域。

为製造商、供应商和医疗保健领导者提供优先考虑的实用建议，以增强供应链韧性、加速临床应用并推动获利成长。

产业领导者应采取一系列优先且切实可行的措施，以保障供应、加速产品推广并维持利润率。首先，应加强供应商多元化和库存策略，以降低贸易政策波动和对单一供应商依赖的影响。投资区域性生产和委託製造方案，有助于快速回应区域需求变化，同时增强市场韧性。其次，应使研发重点与临床路径需求一致。这意味着应着重研发能够提高手术效率、减少鸦片类药物使用量并简化门诊和居家医疗的製剂。

采用稳健的混合调查方法，结合对临床医生和采购负责人的访谈、法规和专利分析以及供应链图谱，对研究洞察检验。

本研究采用混合方法，确保分析的广度和深度。主要研究包括对门诊和住院临床医生、采购主管和供应链经理进行结构化访谈，以了解他们的实际偏好、痛点和采购标准。为了补充这些定性信息，本研究还进行了监管审查和产品附加檔分析，以了解主要司法管辖区的核准途径、附加檔差异和上市后承诺。製造和采购评估结合了供应商分布图、产能评估和情境分析，以检验在贸易政策和需求衝击下的韧性。

这份简明扼要的结论综述将临床优先事项、供应韧性和商业化需求连结起来，并概述了相关人员的策略要务。

总之，局部麻醉领域在基础科学方面已趋于成熟，商业性和营运发展也充满活力。疗效、安全性和持续时间等临床需求仍然是药物选择的指南原则，而製剂创新和给药平台则为差异化提供了重要的机会。贸易政策的变化和供应链的重组凸显了供应商多元化和区域化生产策略的重要性。在各个地区和医疗机构中，能够将严谨的临床证据与切实可行的给药方式相结合，并在手术效率和患者疗效方面展现出显着价值的机构将取得最大的成功。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 扩大脂质性局部麻醉剂配方，以降低全身毒性风险
  • 整合数位化监测平台以优化局部麻醉剂剂量和安全性
  • 增加对长效麻醉技术的投资，以实现更长的术后镇痛
  • 超音波引导神经阻断技术的应用将推动对缓释性的需求。
  • 包含新型局部麻醉剂的非鸦片类多药镇痛通讯协定的出现
  • 提高新型、更安全、心臟毒性风险较低的酰胺类麻醉剂的核准
  • 在临床实务中，缓释性麻醉剂植入在慢性疼痛管理的应用日益广泛。
  • 用于精确局部皮肤麻醉的经皮给药系统的技术进步
  • 专业药房分散式配发个人化局部麻醉剂混合物的成长
  • 製药公司和医疗设备公司伙伴关係开发智慧麻醉剂输送技术

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依给药途径分類的局部麻醉剂市场

  • 浸润
  • 神经阻断
  • 区域
  • 脊椎
  • 局部的

第九章局部麻醉剂市场（依药物类别划分）

  • 酰胺
    • Bupivacaine
    • Lidocaine
    • Mepivacaine
    • Prilocaine
    • Ropivacaine
  • 酯
    • Benzocaine
    • 普鲁卡因
    • 丁卡因

第十章局部麻醉剂市场（依产品类型划分）

  • 奶油
  • 凝胶
  • 注射
  • 修补
  • 喷

第十一章局部麻醉剂市场（依剂型划分）

  • 多剂量管瓶
  • 粉末
  • 预填充式注射器
  • 单剂量安瓿

第十二章 依最终用户分類的局部麻醉剂市场

  • 门诊手术中心
    • 独立的
    • 医院相关
  • 牙医诊所
  • 居家医疗
  • 医院
    • 私立医院
    • 公立医院

第十三章局部麻醉剂市场依通路划分

  • 医院药房
  • 网路药房
    • 直接从製造商购买
    • 网路聚合器
  • 零售药房
    • 链
    • 独立的

第十四章局部麻醉剂市场依应用领域划分

  • 牙科
  • 皮肤科
  • 耳鼻喉科
  • 眼科
  • 足病科

第十五章 各地区局部麻醉剂市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章局部麻醉剂市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章 各国局部麻醉剂市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Pfizer Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Viatris Inc.
    • Sandoz International GmbH
    • Fresenius Kabi AG
    • Hikma Pharmaceuticals PLC
    • B. Braun Melsungen AG
    • Aspen Pharmacare Holdings Ltd.
    • Amneal Pharmaceuticals, Inc.
    • Sun Pharmaceutical Industries Ltd.
Product Code: MRR-742BD5180AE5

The Local Anesthesia Drugs Market is projected to grow by USD 4.34 billion at a CAGR of 5.64% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.80 billion
Estimated Year [2025] USD 2.96 billion
Forecast Year [2032] USD 4.34 billion
CAGR (%) 5.64%

Comprehensive introduction framing clinical imperatives, formulation advances, and commercial forces that are reshaping the global local anesthesia therapeutic landscape

Local anesthesia drugs underpin countless day-to-day clinical procedures, ranging from routine dental interventions to complex regional techniques in ambulatory and hospital settings. Over the past decade, improvements in pharmacokinetics, formulation science, and delivery systems have reframed expectations for efficacy, onset, and duration, while parallel shifts in clinical practice toward outpatient care and opioid stewardship have elevated the strategic importance of local anesthetics in perioperative pathways. Clinicians demand predictable blocks with fewer systemic effects, administrators seek value across care settings, and manufacturers must balance innovation with regulatory rigor and manufacturing scalability.

This introduction frames the current environment by connecting clinical imperatives with commercial realities. It highlights how incremental pharmaceutical innovations-such as extended-release formulations and user-friendly pre-filled systems-interact with broader themes including supply chain resilience, procurement consolidation, and changes in administration settings. The section emphasizes the interplay of evidence generation, clinician training, and reimbursement dynamics that collectively determine adoption curves. By positioning clinical performance, patient experience, and health-economic considerations as co-equal drivers of decision-making, this introduction sets the stage for a focused exploration of recent disruptions, regulatory influences, and actionable recommendations for stakeholders across the ecosystem.

Examination of pivotal technological, clinical practice, supply chain, and digital health shifts that have collectively redefined the competitive landscape for local anesthetic therapies

Recent years have seen transformative shifts that extend beyond simple product substitution, affecting the very modalities by which local anesthesia is developed, manufactured, delivered, and reimbursed. Advances in formulation technology have produced longer-acting and more targeted agents, while combination approaches and device-enabled delivery systems are enabling clinicians to tailor blocks to procedure-specific needs. Concurrently, heightened focus on opioid-sparing protocols and enhanced recovery after surgery pathways has prompted interdisciplinary collaboration that elevates the role of local anesthetics in multimodal analgesia strategies.

At the same time, digital health and perioperative analytics are beginning to influence both clinical decision support and commercial models. Real-world evidence collection and digital dosing tools facilitate more precise administration and post-procedural monitoring, which in turn informs payer conversations and hospital formularies. Supply chain transparency and regulatory scrutiny have intensified, prompting manufacturers to increase vertical integration or qualify multiple suppliers for critical raw materials. These shifts are compounded by changing care-site economics, where ambulatory surgery centers and home-based care models demand compact, user-friendly presentations and simplified administration pathways. Taken together, these dynamics create an environment where clinical efficacy, operational ease, and evidence-based value must converge for new local anesthesia products to achieve sustained adoption.

In-depth analysis of how the 2025 United States tariff measures have reshaped sourcing strategies, manufacturing footprints, and procurement decision-making for local anesthetic supply chains

The tariff landscape introduced in the United States in 2025 has had a cascading influence across manufacturing, sourcing, pricing strategies, and long-term supply chain planning for local anesthesia products. Immediate effects were felt in procurement, where increased import levies on active pharmaceutical ingredients and key excipients elevated landed costs and pressured margin profiles for manufacturers relying on global suppliers. In response, procurement teams accelerated qualification of alternative suppliers and expanded dual-sourcing strategies to mitigate exposure to single-country disruptions.

Longer-term implications include a renewed emphasis on regional manufacturing and nearshoring as companies evaluate trade-offs between landed cost volatility and fixed capital investments. Contract manufacturers and ingredient suppliers located outside tariff-impacted jurisdictions found opportunities to capture incremental demand, while manufacturers exposed to higher import duties began reconfiguring product portfolios to prioritize higher-margin or strategically differentiated formulations. Hospital and clinic procurement processes adjusted to reflect total cost of ownership rather than unit price alone, integrating inventory planning and supplier risk assessments into purchasing decisions.

Moreover, the tariff pressure intensified regulatory and quality assurance conversations, as rapid supplier changes necessitated comprehensive comparability studies and stability testing to support product integrity. Overall, the 2025 tariff actions catalyzed a strategic reassessment of sourcing, manufacturing footprint, and inventory policies, ultimately favoring manufacturers and distributors who could demonstrate supply chain transparency, regulatory compliance, and flexible production capacity.

Advanced segmentation insights synthesizing administration routes, drug classes, product types, formulations, end-user behaviors, distribution channels, and clinical applications to inform strategy

Segment-level dynamics reveal nuanced opportunities and constraints that inform product development and commercialization strategies. When viewed through the lens of route administration, clinical practice differentiates between infiltration techniques used for superficial procedures and nerve block approaches that require precise, longer-acting agents; regional and spinal administration demand products with predictable spread and minimal systemic toxicity; and topical formulations emphasize rapid onset and minimal irritation for dermatologic and minor dental applications. Each route carries distinct clinician training requirements, device compatibility considerations, and safety profiles that should influence formulation and packaging decisions.

Evaluating segmentation by drug class underscores how chemical families drive both clinical choice and formulation strategy. Amide-class agents such as bupivacaine, lidocaine, mepivacaine, prilocaine, and ropivacaine offer varied onset and duration kinetics that inform selection for different procedures, while ester-class agents including benzocaine, procaine, and tetracaine maintain relevance in specific topical and short-duration contexts. Product-type segmentation stretches across creams, gels, injections, patches, and sprays, each presenting different regulatory pathways, patient acceptability factors, and device interfaces. Formulation choices-multi-dose vials, powders, pre-filled syringes, and single-dose ampoules-impact sterility assurance, dosing accuracy, and supply chain logistics, and therefore affect hospital adoption and ambulatory site preference.

End-user segmentation reveals differentiated procurement behaviors and clinical needs across ambulatory surgery centers, dental clinics, home care environments, and hospitals. Within ambulatory surgery centers, distinctions between free-standing and hospital-affiliated entities influence purchasing centralization and contract terms, while hospitals differentiated by private and public ownership exhibit divergent tendering practices and formulary governance. Distribution channels span hospital pharmacies, online pharmacies, and retail pharmacies; online pharmacy models include manufacturer-direct fulfillment and web aggregator platforms, while retail pharmacy distribution divides into chain and independent operators. Finally, application-specific segmentation-dental, dermatology, ENT, ophthalmic, and podiatry-drives demand for targeted formulation attributes, dose forms, and clinician education. Together, these layered segmentation lenses provide a strategic framework for prioritizing investments and tailoring commercial approaches to maximize clinical uptake and operational compatibility.

Strategic regional perspectives highlighting how Americas, Europe Middle East & Africa, and Asia-Pacific markets differ in regulatory expectations, procurement practices, and clinical adoption

Regional variations continue to shape product priorities and go-to-market approaches in meaningful ways. In the Americas, a combination of advanced clinical infrastructure, high outpatient procedure volumes, and evolving payer expectations has increased emphasis on long-acting formulations, pre-filled systems, and solutions that support opioid-sparing care pathways. Supply chain strategies in this region reflect a balance between domestic manufacturing and reliance on established international suppliers, with procurement teams favoring partners who demonstrate regulatory compliance and logistical reliability.

The Europe, Middle East & Africa region presents a heterogeneous mix of regulatory environments and procurement models. Western European markets tend to emphasize rigorous clinical evidence and centralized formulary processes, whereas emerging markets in the Middle East and Africa prioritize cost-effective, robust products that tolerate variable storage and handling conditions. Reimbursement frameworks vary substantially across this region, making localized evidence generation and pricing strategies essential for adoption in public hospital systems and private clinics alike.

In Asia-Pacific, growth is driven by expanding surgical volumes, rapid uptake of ambulatory surgical models, and investments in local manufacturing capacity. Regulatory authorities are increasingly harmonizing requirements, yet country-specific clinical preferences persist, particularly regarding agent selection and presentation formats. Manufacturers targeting this region often combine regional production hubs with targeted clinician engagement and training programs to accelerate acceptance. Across all regions, partnerships with local distributors, investment in clinician education, and responsiveness to logistics challenges remain critical to securing sustainable access and uptake.

Illuminating competitive dynamics among innovators, generics manufacturers, contract producers, and device-integrated firms that are shaping the future landscape of local anesthetic development and commercialization

Company-level dynamics reflect a competitive interplay between innovators, generics manufacturers, contract producers, and integrated device-drug firms. Innovator organizations continue to invest in extended-release chemistries and proprietary delivery platforms that offer differentiation in duration, safety, or ease of administration. These investments are frequently supported by targeted clinical programs that demonstrate benefits in procedure-specific endpoints and patient-reported outcomes. At the same time, generics manufacturers maintain significant influence in commoditized segments, where cost-effectiveness and supply reliability drive purchasing decisions, particularly in high-volume applications such as dental and basic infiltration anesthesia.

Contract manufacturing organizations and specialty fill-finish partners have become strategic allies as the industry seeks flexible capacity and rapid scale-up capabilities. Device-drug combination players, particularly those offering pre-filled syringes, patches, or integrated delivery tools, are carving niches by addressing clinician workflow and dosing accuracy. Strategic partnerships, licensing arrangements, and selective acquisitions are common mechanisms firms use to extend portfolios, secure distribution channels, or access localized manufacturing capabilities. Across the competitive landscape, the most successful companies combine robust regulatory and quality systems with nimble commercial models and demonstrable clinical value propositions that resonate with hospital formulary committees and outpatient care purchasers.

Practical, prioritized recommendations for manufacturers, suppliers, and healthcare leaders to strengthen supply resilience, accelerate clinical adoption, and drive profitable growth

Industry leaders should pursue a set of prioritized, actionable moves to safeguard supply, accelerate adoption, and preserve margin. First, strengthen supplier diversification and inventory strategies to reduce exposure to trade policy volatility and single-source dependencies. Investing in regional or contract manufacturing options can create resilience while enabling faster responsiveness to local demand shifts. Second, align R&D priorities with clinical pathway needs by targeting formulations that demonstrably improve procedure efficiency, reduce opioid use, or simplify administration in ambulatory and home care settings; evidence packages that include patient-reported outcomes and health-economic modeling will facilitate payer and formulary conversations.

Third, optimize commercial approaches by pairing targeted clinician education with product formats that match care-site workflows, such as pre-filled syringes for high-throughput ambulatory centers or patches for dermatologic procedures. Fourth, explore partnerships and licensing deals with device manufacturers and digital health providers to create differentiated offerings that address both safety and usability. Fifth, incorporate total cost of ownership analyses into pricing and contracting to reflect inventory, wastage, and administration efficiencies rather than unit price alone. Finally, embed regulatory and quality-by-design principles early in product development to minimize comparability work when qualifying alternate suppliers and to accelerate approvals in multiple jurisdictions. Taken together, these recommendations balance near-term risk mitigation with medium-term growth and differentiation opportunities.

Robust mixed-methods research methodology integrating primary clinician and procurement interviews, regulatory and patent analysis, and supply chain mapping to validate insights

This research relied on a mixed-methods approach designed to ensure both breadth and depth in the analysis. Primary research included structured interviews with clinicians, purchasing leads, and supply chain managers across ambulatory and hospital settings to capture real-world preferences, pain points, and procurement criteria. Supplementing these qualitative inputs, regulatory reviews and product dossier analyses were performed to understand approval pathways, labeling differences, and post-marketing commitments across major jurisdictions. Manufacturing and sourcing assessments combined supplier mapping, capacity evaluations, and scenario analysis to examine resilience under trade policy and demand shocks.

Secondary research encompassed systematic reviews of peer-reviewed clinical literature, procedure volume data, and publicly available regulatory documents to triangulate clinical performance claims and safety profiles. Patent landscaping and intellectual property reviews informed the assessment of innovation lifecycles and freedom-to-operate considerations. Data quality assurance was achieved through cross-validation of primary interview themes with secondary sources and follow-up expert validation sessions. Limitations include potential variability in regional procurement practices and differences in country-level coding of procedure types; where relevant, regional caveats are explicitly stated. Methodological transparency and rigorous triangulation underpin the findings and recommendations presented in the report.

Concise concluding synthesis that connects clinical priorities, supply resilience, and commercialization imperatives to outline strategic imperatives for stakeholders

In conclusion, the local anesthesia landscape is simultaneously mature in its foundational science and dynamic in its commercial and operational evolution. Clinical imperatives around efficacy, safety, and duration continue to guide agent selection, while formulation innovation and delivery platforms provide meaningful opportunities for differentiation. Trade policy shifts and supply chain reconfigurations underscore the importance of supplier diversification and regional manufacturing strategies. Across regions and care settings, success will favor organizations that can align rigorous clinical evidence with practical administration formats and demonstrate clear value in terms of procedure efficiency and patient outcomes.

Decision-makers should prioritize investments that enhance supply resilience, streamline clinician workflows, and generate compelling real-world evidence. By adopting an integrated approach that spans R&D, manufacturing strategy, and localized commercialization, stakeholders can convert technical innovation into durable market access. The sectors poised for growth are those that marry clinical credibility with operational pragmatism, ensuring that new products not only perform in controlled trials but also scale effectively within the logistical and economic realities of contemporary healthcare delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Expansion of lipid-based local anesthetic formulations to reduce systemic toxicity risk
  • 5.2. Integrating digital monitoring platforms to optimize dosing and safety of local anesthetics
  • 5.3. Growing investment in long-acting anesthetic technologies for prolonged postoperative analgesia
  • 5.4. Adoption of ultrasound-guided nerve block procedures boosting demand for extended-release formulations
  • 5.5. Emergence of non-opioid multimodal analgesia protocols incorporating novel local anesthetics
  • 5.6. Rising regulatory approvals of safer novel amide-based anesthetics with reduced cardiotoxicity risk
  • 5.7. Increasing use of sustained-release anesthetic implants for chronic pain management in clinics
  • 5.8. Technological advances in transdermal delivery systems for precise localized dermal anesthesia applications
  • 5.9. Growth in decentralized compounding of personalized local anesthesia mixtures by specialty pharmacies
  • 5.10. Partnerships between pharma and medical device firms to develop smart anesthetic delivery technologies

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Local Anesthesia Drugs Market, by Route Administration

  • 8.1. Infiltration
  • 8.2. Nerve Block
  • 8.3. Regional
  • 8.4. Spinal
  • 8.5. Topical

9. Local Anesthesia Drugs Market, by Drug Class

  • 9.1. Amides
    • 9.1.1. Bupivacaine
    • 9.1.2. Lidocaine
    • 9.1.3. Mepivacaine
    • 9.1.4. Prilocaine
    • 9.1.5. Ropivacaine
  • 9.2. Esters
    • 9.2.1. Benzocaine
    • 9.2.2. Procaine
    • 9.2.3. Tetracaine

10. Local Anesthesia Drugs Market, by Product Type

  • 10.1. Cream
  • 10.2. Gel
  • 10.3. Injection
  • 10.4. Patch
  • 10.5. Spray

11. Local Anesthesia Drugs Market, by Formulation

  • 11.1. Multi-dose Vial
  • 11.2. Powder
  • 11.3. Pre-filled Syringe
  • 11.4. Single-dose Ampoule

12. Local Anesthesia Drugs Market, by End-User

  • 12.1. Ambulatory Surgery Centers
    • 12.1.1. Free-standing
    • 12.1.2. Hospital-affiliated
  • 12.2. Dental Clinics
  • 12.3. Home Care
  • 12.4. Hospitals
    • 12.4.1. Private Hospitals
    • 12.4.2. Public Hospitals

13. Local Anesthesia Drugs Market, by Distribution Channel

  • 13.1. Hospital Pharmacy
  • 13.2. Online Pharmacy
    • 13.2.1. Manufacturer Direct
    • 13.2.2. Web Aggregators
  • 13.3. Retail Pharmacy
    • 13.3.1. Chain
    • 13.3.2. Independent

14. Local Anesthesia Drugs Market, by Application

  • 14.1. Dental
  • 14.2. Dermatology
  • 14.3. ENT
  • 14.4. Ophthalmic
  • 14.5. Podiatry

15. Local Anesthesia Drugs Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Local Anesthesia Drugs Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Local Anesthesia Drugs Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Pfizer Inc.
    • 18.3.2. Teva Pharmaceutical Industries Ltd.
    • 18.3.3. Viatris Inc.
    • 18.3.4. Sandoz International GmbH
    • 18.3.5. Fresenius Kabi AG
    • 18.3.6. Hikma Pharmaceuticals PLC
    • 18.3.7. B. Braun Melsungen AG
    • 18.3.8. Aspen Pharmacare Holdings Ltd.
    • 18.3.9. Amneal Pharmaceuticals, Inc.
    • 18.3.10. Sun Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. NORTH AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. LATIN AMERICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. EUROPE LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. MIDDLE EAST LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AFRICA LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASEAN LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GCC LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRICS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. G7 LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NATO LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. LOCAL ANESTHESIA DRUGS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. LOCAL ANESTHESIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. LOCAL ANESTHESIA DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INFILTRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INFILTRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INFILTRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INFILTRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INFILTRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INFILTRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY NERVE BLOCK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY NERVE BLOCK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY NERVE BLOCK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY NERVE BLOCK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY NERVE BLOCK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY NERVE BLOCK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGIONAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGIONAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGIONAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGIONAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGIONAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGIONAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SPINAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SPINAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SPINAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SPINAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SPINAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SPINAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TOPICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TOPICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY BUPIVACAINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY BUPIVACAINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY BUPIVACAINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY BUPIVACAINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY BUPIVACAINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY BUPIVACAINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY LIDOCAINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY LIDOCAINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY LIDOCAINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY LIDOCAINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY LIDOCAINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY LIDOCAINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MEPIVACAINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MEPIVACAINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MEPIVACAINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MEPIVACAINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MEPIVACAINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MEPIVACAINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRILOCAINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRILOCAINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRILOCAINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRILOCAINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRILOCAINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRILOCAINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROPIVACAINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROPIVACAINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROPIVACAINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROPIVACAINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROPIVACAINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROPIVACAINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY BENZOCAINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY BENZOCAINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY BENZOCAINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY BENZOCAINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY BENZOCAINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY BENZOCAINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PROCAINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PROCAINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PROCAINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PROCAINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PROCAINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PROCAINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TETRACAINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TETRACAINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TETRACAINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TETRACAINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TETRACAINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY TETRACAINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY CREAM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY CREAM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY CREAM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY CREAM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY CREAM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY CREAM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY GEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY GEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY GEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY GEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY GEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY GEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INJECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INJECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INJECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INJECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INJECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INJECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PATCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PATCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PATCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PATCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PATCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PATCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SPRAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SPRAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SPRAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SPRAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SPRAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SPRAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MULTI-DOSE VIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MULTI-DOSE VIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MULTI-DOSE VIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MULTI-DOSE VIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MULTI-DOSE VIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MULTI-DOSE VIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY POWDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY POWDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY POWDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY POWDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRE-FILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRE-FILLED SYRINGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRE-FILLED SYRINGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRE-FILLED SYRINGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRE-FILLED SYRINGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRE-FILLED SYRINGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SINGLE-DOSE AMPOULE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SINGLE-DOSE AMPOULE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SINGLE-DOSE AMPOULE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SINGLE-DOSE AMPOULE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SINGLE-DOSE AMPOULE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SINGLE-DOSE AMPOULE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY FREE-STANDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY FREE-STANDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY FREE-STANDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY FREE-STANDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY FREE-STANDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY FREE-STANDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITAL-AFFILIATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITAL-AFFILIATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITAL-AFFILIATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITAL-AFFILIATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITAL-AFFILIATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITAL-AFFILIATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DENTAL CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DENTAL CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DENTAL CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DENTAL CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOME CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MANUFACTURER DIRECT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MANUFACTURER DIRECT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MANUFACTURER DIRECT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MANUFACTURER DIRECT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MANUFACTURER DIRECT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY MANUFACTURER DIRECT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY WEB AGGREGATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY WEB AGGREGATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY WEB AGGREGATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY WEB AGGREGATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY WEB AGGREGATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY WEB AGGREGATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY CHAIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY CHAIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY CHAIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY CHAIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY CHAIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY CHAIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INDEPENDENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INDEPENDENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INDEPENDENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INDEPENDENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY INDEPENDENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DENTAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DENTAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DENTAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DENTAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DENTAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DERMATOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DERMATOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DERMATOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DERMATOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DERMATOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY OPHTHALMIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY OPHTHALMIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY OPHTHALMIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY OPHTHALMIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY OPHTHALMIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY OPHTHALMIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PODIATRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PODIATRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PODIATRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PODIATRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PODIATRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PODIATRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL LOCAL ANESTHESIA DRUGS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 297. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 298. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 299. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 300. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ROUTE ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 301. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
  • TABLE 302. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2032 (USD MILLION)
  • TABLE 303. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, 2018-2024 (USD MILLION)
  • TABLE 304. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMIDES, 2025-2032 (USD MILLION)
  • TABLE 305. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, 2018-2024 (USD MILLION)
  • TABLE 306. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ESTERS, 2025-2032 (USD MILLION)
  • TABLE 307. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 310. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 311. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 312. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 313. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 314. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 315. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 316. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 317. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 318. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 319. AMERICAS LOCAL ANESTHESIA DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (